Johnson Kevin Bruce
SEC insider (Form 3/4/5 filer). CIK 0001994710. Chief Regulatory Officer at Tourmaline Bio, Inc. (TRML). 4 reported Form 4/5 transactions since Sep 2024; latest on Oct 28, 2025. Located in NEW YORK, NY.
Companies Johnson Kevin Bruce has filed insider reports for
- Tourmaline Bio, Inc. (TRML): Officer, Chief Regulatory Officer
Johnson Kevin Bruce
CIK: 0001994710
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (25.0%)
Compensation grants
Other (G, F, J, C, D, …)3 (75.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
TRML
Tourmaline Bio, Inc.
Officer
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Oct 28, 2025TRML
Tourmaline Bio, Inc.
Tender OfferDirect40.5K shares- - Oct 28, 2025TRML
Tourmaline Bio, Inc.
DispositionDirect11K shares- - Oct 15, 2025TRML
Tourmaline Bio, Inc.
GiftDirect6.3K shares- - Jan 27, 2025TRML
Tourmaline Bio, Inc.
AwardDirectEmployee Stock Option (Right to Buy)
58K shares-
1-4 of 4 transactions